MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$31,589,251
Net Income
$18,593,806
Net Profit Margin
58.86%
EPS
$0.01
Unit: Dollar
Revenue Breakdown
Manufacturing
Licensing
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Total revenue
31,589,251
36,321,704
40,211,097
31,996,273
Cost of manufacturing
18,636,076
22,248,671
12,985,127
14,701,165
Gross profit
12,953,175
14,073,033
27,225,970
17,295,108
Research and development
1,040,665
1,385,306
1,674,964
2,041,413
General and administrative
2,466,336
4,029,199
3,404,084
2,034,416
Impairment of intangible assets
-
-
-
-1,603,426
Non-cash compensation through issuance of stock options
45,096
49,918
52,329
52,329
Depreciation and amortization
388,135
394,864
394,886
409,865
Total operating expenses
3,940,232
5,859,287
5,526,263
6,141,449
Income from operations
9,012,943
8,213,746
21,699,707
11,153,659
Change in fair value of derivative financial instruments - warrants
11,817,375
7,519,649
-22,109,537
8,365,831
Other income
-
34,500
0
-
Interest expense and amortization of debt issuance costs
80,204
82,470
158,926
188,843
Interest income
83,602
4,922
4,542
4,560
Other income (expense), net
11,820,773
7,476,601
-22,263,921
8,118,240
Income (gain) before income taxes
20,833,716
15,690,347
-564,214
19,271,899
Income tax expense
2,239,910
1,987,940
5,320,501
2,274,162
Net income (gain)
18,593,806
13,702,407
-5,884,715
16,997,737
Basic EPS
0.02
0.01
-0.01
-
Diluted EPS
0.01
0.01
-0.01
-
Basic Average Shares
1,074,115,101
1,071,897,174
1,068,363,108
1,068,342,148
Diluted Average Shares
1,140,876,178
1,141,536,381
1,068,363,108
1,060,365,052
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Manufacturing
$31,383,684
(128.44%↑ Y/Y)
Licensing
$205,567
(-67.17%↓ Y/Y)
Total revenue
$31,589,251
(119.92%↑ Y/Y)
Change in fair value of
derivative financial...
$11,817,375
(200.75%↑ Y/Y)
Interest income
$83,602
(1541.83%↑ Y/Y)
Gross profit
$12,953,175
(111.68%↑ Y/Y)
Cost of
manufacturing
$18,636,076
(126.03%↑ Y/Y)
Other income
(expense), net
$11,820,773
(200.60%↑ Y/Y)
Income from operations
$9,012,943
(720.99%↑ Y/Y)
Interest expense and
amortization of debt issuance...
$80,204
(3.35%↑ Y/Y)
Total operating
expenses
$3,940,232
(-21.53%↓ Y/Y)
Income (gain) before
income taxes
$20,833,716
(295.57%↑ Y/Y)
General and
administrative
$2,466,336
(-9.48%↓ Y/Y)
Research and development
$1,040,665
(-41.99%↓ Y/Y)
Depreciation and
amortization
$388,135
(-10.26%↓ Y/Y)
Non-cash compensation
through issuance of...
$45,096
(-36.10%↓ Y/Y)
Net income (gain)
$18,593,806
(270.71%↑ Y/Y)
Income tax expense
$2,239,910
(836.52%↑ Y/Y)
Buy us a coffee
ELITE PHARMACEUTICALS INC NV (ELTP)
ELITE PHARMACEUTICALS INC NV (ELTP)